Home › NDC Lookup › RxCUI directory › RxCUI 198105

Pindolol 5 MG Oral Tablet — RxCUI 198105

RxNorm drug concept · Semantic clinical drug
RxCUI 198105 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198105
Official namePindolol 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped15
Package NDCs mapped15
Reported Medicaid activity (SDUD)3,081 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pindolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pindolol is used to manage high blood pressure. You can take it alone or with other blood pressure medicines, often a water pill.
  • Blood pressure often starts to come down within the first week. The full effect can take 2 weeks or longer. Your doctor may adjust the dose after 3 to 4 weeks if needed.
  • No. Stopping suddenly can make chest pain worse and, in some people, trigger a heart attack. If you need to stop, your doctor will lower the dose gradually over 1 to 2 weeks.
  • Common ones include trouble sleeping, muscle or joint pain, dizziness, tiredness, nervousness, and swelling. Call your doctor for shortness of breath, wheezing, a very slow heartbe...
📖 Read our full Pindolol guide →

🕸️ Concept Web — How Pindolol 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pindolol 5 MG Oral Tablet RxCUI 198105

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pindolol 8332
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pindolol Oral Tablet 373460
    • Pindolol Oral Product 1159271
    • Pindolol Pill 1159272
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pindolol 5 MG 316522

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pindolol 5 MG SCDC · 316522
  • Pindolol Oral Tablet SCDF · 373460
  • Pindolol Oral Product SCDG · 1159271
  • Pindolol Pill SCDG · 1159272

📦 FDA Products & Package NDCs

15 products · 15 package NDCs
15 package NDCs map to RxCUI 198105 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10135-0743-01 100 TABLET in 1 BOTTLE (10135-743-01) Pindolol Marlex Pharmaceuticals, Inc. 2022-06-01
10135-0744-01 100 TABLET in 1 BOTTLE (10135-744-01) Pindolol Marlex Pharmaceuticals, Inc. 2022-06-01
57664-0655-88 100 TABLET in 1 BOTTLE, PLASTIC (57664-655-88) Pindolol Sun Pharmaceutical Industries, Inc. 1994-01-27
57664-0656-88 100 TABLET in 1 BOTTLE, PLASTIC (57664-656-88) Pindolol Sun Pharmaceutical Industries, Inc. 1994-01-27
62559-0560-01 100 TABLET in 1 BOTTLE (62559-560-01) Pindolol ANI Pharmaceuticals, Inc. 2017-05-08
62559-0561-01 100 TABLET in 1 BOTTLE (62559-561-01) Pindolol ANI Pharmaceuticals, Inc. 2017-05-08
63629-4828-01 180 TABLET in 1 BOTTLE, PLASTIC (63629-4828-1) Pindolol Bryant Ranch Prepack 2024-11-25
69367-0421-01 100 TABLET in 1 BOTTLE (69367-421-01) Pindolol Westminster Pharmaceuticals, LLC 2025-11-18
69367-0422-01 100 TABLET in 1 BOTTLE (69367-422-01) Pindolol Westminster Pharmaceuticals, LLC 2025-11-18
72162-2652-01 100 TABLET in 1 BOTTLE (72162-2652-1) Pindolol Bryant Ranch Prepack 2026-05-27
72789-0099-01 100 TABLET in 1 BOTTLE, PLASTIC (72789-099-01) Pindolol PD-Rx Pharmaceuticals, Inc. 2020-07-15
72789-0100-01 100 TABLET in 1 BOTTLE, PLASTIC (72789-100-01) Pindolol PD-Rx Pharmaceuticals, Inc. 2020-07-15
72789-0294-01 100 TABLET in 1 BOTTLE, PLASTIC (72789-294-01) Pindolol PD-Rx Pharmaceuticals, Inc. 2023-01-11
76385-0131-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-131-01) Pindolol Unichem Pharmaceuticals (USA), Inc. 2020-02-01
76385-0132-01 100 TABLET in 1 BOTTLE, PLASTIC (76385-132-01) Pindolol Unichem Pharmaceuticals (USA), Inc. 2020-02-01
Observed labelers: PD-Rx Pharmaceuticals, Inc. (3) · ANI Pharmaceuticals, Inc. (2) · Bryant Ranch Prepack (2) · Marlex Pharmaceuticals, Inc. (2) · Sun Pharmaceutical Industries, Inc. (2) · Unichem Pharmaceuticals (USA), Inc. (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.